Company profile for Brii Biosciences

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. Unfortunately, these innovations have not always reached China or the patients in China who need them. Breakthroughs in science and technology, and advances in digital and data capabilities, are poised to disrupt the discovery, development and delivery of medicines. At the same time,...
The pace of innovation has accelerated over the past decade, resulting in dramatically better treatments and cures for life-threatening diseases. Unfortunately, these innovations have not always reached China or the patients in China who need them. Breakthroughs in science and technology, and advances in digital and data capabilities, are poised to disrupt the discovery, development and delivery of medicines. At the same time, the regulatory environment in China has improved significantly.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
WeWork One City Center, Unit 05-130, 110 Corcoran Street, Durham, NC 27701
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/brii-biosciences-presents-late-breaking-data-from-ongoing-phase-2-ensure-study-at-aasld-2025-reinforcing-brii-179s-potential-as-a-curative-treatment-for-chronic-hepatitis-b-302609694.html

PR NEWSWIRE
10 Nov 2025

https://www.prnewswire.com/news-releases/brii-biosciences-announces-publication-of-phase-2-ensure-study-results-in-nature-medicine-302608328.html

PR NEWSWIRE
07 Nov 2025

https://www.prnewswire.com/news-releases/brii-biosciences-provides-corporate-updates-and-reports-2025-interim-financial-results-302535331.html

PR NEWSWIRE
21 Aug 2025

https://www.prnewswire.com/news-releases/brii-biosciences-announces-licensing-agreement-with-joincare-group-for-rights-to-brii-693-in-greater-china-302498047.html

PR NEWSWIRE
03 Jul 2025

https://www.prnewswire.com/news-releases/brii-bio-presents-late-breaking-data-from-its-ongoing-phase-2-ensure-study-at-easl-congress-2025-suggesting-brii-179s-role-in-advancing-higher-hbsag-loss-302449359.html

PR NEWSWIRE
07 May 2025

https://www.prnewswire.com/news-releases/brii-bio-unveils-new-data-from-its-ongoing-phase-2-ensure-study-at-apasl-2025-showcasing-brii-179s-unique-potential-to-prime-and-boost-higher-hbsag-loss-through-target-patient-identification-302415033.html

PR NEWSWIRE
30 Mar 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty